Premature ovarian failure and ovarian autoimmunity

Endocrine Reviews

Volumn 18, Issue 1, 1997, Pages 107-134

  Hoek, A ^a   Schoemaker, J ^b   Drexhage, H A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; FOLLITROPIN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR; THYROTROPIN;

ADDISON DISEASE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CLONAL ANERGY; DRUG THERAPY; EFFECTOR CELL; GENETIC PREDISPOSITION; GRAVES DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; MYASTHENIA GRAVIS; NONHUMAN; OVARY INFLAMMATION; OVARY INSUFFICIENCY; OVULATION INDUCTION; PRIORITY JOURNAL; THYMECTOMY; ZONA PELLUCIDA;

ADDISON DISEASE; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; OVARIAN FAILURE, PREMATURE; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0031049942     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.18.1.107     Document Type: Article

References (318)

1. de Moraes-Ruehsen M, Jones GS 1967 Premature ovarian failure. Fertil Steril 18:440-461
2. Singh RP, Carr DH 1966 The anatomy and histology of XO human embryos and fetuses. Anat Rec 155:369-383
3. Villanueva AL, Rebar RW 1983 Triple-X syndrome and premature ovarian failure. Obstet Gynecol 62[Suppl 3]:70s-73s
4. Fitch N, de Saint Victor J, Richer CL, Pinsky L, Sitahal S 1982 Premature menopause due to a small deletion in the long arm of the x chromosome: a report of three cases and a review. Am J Obstet Gynecol 142:968-972
5. Krauss CM, Turksoy RN, Atkins L, McLaughin C, Brown L, Page DC 1987 Familial premature ovarian failure due to an interstitial deletion of the long arm of the x chromosome. N Engl J Med 317:125-131
6. Trunca C, Therman E, Rosenwaks Z 1984 The phenotypic effect of small, distal Xq deletions. Hum Genet 68:87-89
7. Fitzgerald PH, Donald RA, McCormick P 1984 Reduced fertility in women with chromosome abnormalities. Clin Genet 25:301-309
8. Hens L, Devroey P, van Waesberghe L, Bonduelle M, van Steirteghem AC, Liebaers I 1989 Chromosome studies and fertility treatment in women with ovarian failure. Clin Genet 36:81-91
9. Plunkett ER, Garner PR 1972 Ovarian failure: possible etiological mechanisms. In: Velardo JT, Kasprow BA (eds) Biology of Reproduction: Basic and Clinical studies. Presented at the Pan American Congress of Anatomy, New Orleans, pp 235-239
10. Smith A, Fraser IS, Noel M 1979 Three siblings with premature gonadal failure. Fertil Steril 32:528-530
11. Coulam CB, Stringfellow S, Hoefnagel D 1983 Evidence for a genetic factor in the etiology of premature ovarian failure. Fertil Steril 40:693-695
12. Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, Schulman JD 1984 Familial premature ovarian failure. Am J Hum Genet 36:1341-1348
13. Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD 1981 Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 214:1145-1147
14. Kaufman F, Kogut MD, Donnell GN, Koch R, Goebelsmann U 1979 Ovarian failure in galactosemia. Lancet 2:737-738
15. Waxman J 1983 Chemotherapy and the adult gonad: a review. J R Soc Med 76:144-148
16. Warne GI Fairley KF, Hobbs JB, Martin FIR 1973 Cyclophosphamide-induced ovarian failure. N Engl J Med 289:1159-1162
17. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Bearwell CG 1983 The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 52:988-993
18. Le Floch O, Donaldson SS, Kaplan HS 1976 Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer 38:2263-2268
19. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Meigs JW, Strong LC, Myers MH, Mulvihill JJ 1992 Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166: 788-793
20. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA 1981 Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 304:1377-1382
21. Morrison JC, Givens JR, Wiser WL, Fish SA 1975 Mumps oöphoritis: a cause of premature menopause. Fertil Steril 26:655-659
22. Prinz W, Taubert HD 1969 Mumps in pubescent females and its effect on later reproductive function. Gynaecologia 167:23-27
23. Coulam CB 1982 Premature gonadal failure. Fertil Steril 38:645-655
24. Jaszmann L, van Lith ND, Zaat JCA 1969 The age at menopause in the Netherlands: the statistical analysis of a survey. Int J Fertil 14:106-117
25. Krailo MD, Pike MC 1983 Estimation of the distribution of ago at natural menopause from prevalence data. Am J Epidemiol 117: 356-361
26. Walsh RJ 1978 The age of menopause of Australian women. Med J Aust 2:181-182
27. Baker TG 1973 A quantatitive and cytological study of germ cells in human ovaries. Proc R Soc Lond [Biol] 158:417-433
28. Block E 1952 Quantitative morphological investigations of the follicular system in women. Variations at different ages. Acta Anat (Basel) 14:108-123
29. Costoff A, Mahesh VB 1975 Primordial follicles with normal oocytes in the ovaries of postmenopausal women. J Am Geriatr Soc 23:193-196
30. Cameron IT, O'Shea FC, Rolland JM, Hughes EG, de Kretser DM, Healy DL 1988 Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 67:1190-1194
31. Heller CG, Heller EJ 1939 Gonadotropic hormone: assays of normal cycling, menopausal, castrated and estrin treated females. J Clin Invest 18:171-178
32. Atria A 1950 La menopausia precoz y su tratamiento hormonal. Rev Med Chile 78:373-377
33. Starup J, Sele V 1973 Premature ovarian failure. Acta Obstet Gynecol Scand 52:259-268
34. Alper MM, Garner PR 1985 Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 66:27-30
35. Philip J, Sele V, Trolle D 1966 Secondary hypergonadotrophic amenorrhea. Acta Obstet Gynecol Scand 45:142-147
36. Sele V, Starup J 1971 Premature ovarian failure. Acta Obstet Gynecol Scand 50:24
37. Zarate A, Karchmer S, Gomez E, Castelazo-Ayala L 1970 Premature menopause. A clinical, histologic, and cytogenetic study. Am J Obstet Gynecol 106:110-114
38. Emperaire JC, Audebert A, Greenblatt RB 1970 Premature ovarian failure. Report of seven cases. Am J Obstet Gynecol 108:445-449
39. Starup J, Sele V, Henriksen B 1971 Amenorrhoea associated with increased production of gonadotrophins and morphologically normal ovarian follicular apparatus. Acta Endocrinol (Copenh) 66: 248-256
40. Yen SS, Tsai CC, Vandenberg G, Rebar R 1972 Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation. J Clin Endocrinol Metab 35:897-904
41. Rebar RW, Erickson GF, Yen SS 1982 Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 37: 35-41
42. Alper MM, Jolly EE, Garner PR 1986 Pregnancies after premature ovarian failure. Obstet Gynecol 67[Suppl 3]:59s-62s
43. Schreiber JR, Davajan V, Kletsky OA 1978 A case of intermittent ovarian failure. Am J Obstet Gynecol 132:698-699
44. Alper MM, Garner PR, Seibel MM 1986 Premature ovarian failure: current concepts. J Reprod Med 31:699-708
45. Wright CS, Jacobs HS 1979 Spontaneous pregnancy in a patient with hypergonadotropic ovarian failure. Br J Obstet Gynecol 86: 389-392
46. Jeppsson S, Ljungberg O, Rannevik G 1980 Hypergonadotropic hypogonadism with preserved fertility: a new syndrome? Acta Endocrinol (Copenh) 95:388-392
47. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, Shawker TH, Merino MJ 1994 Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 79: 1470-1475
48. Coulam CB, Adamson SC, Annegers JF 1986 Incidence of premature ovarian failure. Obstet Gynecol 67:604-606
49. Kinch RAH, Plunkett ER, Smout MS, Carr DH 1965 Primary ovarian failure: a clinicopathological and cytogenetic study. Am J Obstet Gynecol 91:630-641
50. Jones GS, de Moraes-Ruehsen M 1969 A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 104:597-600
51. Fraser IS, Shearman RF, Smith A, Russell P 1988 An association among blepharophimosis, resistant ovary syndrome, and true premature menopause. Fertil Steril 50:747-751
52. Panidis D, Rousso D, Vavilis D, Skiadopoulos S, Kalogeropoulos A 1994 Case report. Familial blepharophimosis with ovarian dysfunction. Hum Reprod 9:2034-2037
53. Fraser IS, Russell P, Greco S, Robertson DM 1986 Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clin Reprod Fertil 4:133-138
54. Townsend A, Bodmer H 1989 Antigen recognition by class I restricted T lymphocytes. Annu Rev Immunol 7:601-624
55. Hill JA, Welch WR, Faris HMP, Anderson DJ 1990 Induction of class II major histocompatibility complex antigen expression in human granulosa cells by interferon gamma: a potential mechanism contributing to autoimmune ovarian failure. Am J Obstet Gynecol 162:534-540
56. Freudenthal PS, Steinman RM 1990 The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci 87:7698-7702
57. Weetman AP 1991 Immunogenetics and autoimmunity. In: Weetman AP (ed) Autoimmune Endocrine Disease. Cambridge Reviews in Clinical Immunology. Cambridge University Press, pp 39-65
58. Strominger JL 1987 Structure class I and class II HLA antigens. Br Med Bull 43:81-93
59. Pure E, Inaba K, Crowley MT, Tardelli L, Witmer-Pack MD, Ruberti G, Fathman G, Steinman RM 1990 Antigen processing by epidermal Langerhans cells correlates with level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med 172:1459-1469
60. Neefjes JJ, Ploegh HL 1992 Intracellular transport of MHC class II molecules. Immunol Today 13:179-184
61. Harding CV 1993 Cellular and molecular aspects of antigen processing and the function of class II molecules. Am J Respir Cell Mol Biol 8:461-467
62. Rock KL, Rothstein L, Gamble S, Fleischacker C 1993 Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150:438-446
63. Rudensky AYu Preston-Hulburt P, Hong SC, Barlow A, Janeway Jr CA 1991 Sequence analysis of peptide bound to MHC class II molecules. Nature 353:622-627
64. Monaco JJ, McDevitt HO 1984 H-2 linked low-molecular weight polypeptide antigens assemble into an unusual macromolecular complex. Nature 309:797-799
65. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG 1991 Allele-specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature 351:290-296
66. Teh HS, Kisielow P, Scott B, Kishi H, Vematsu Y, Bluthmann H, von Boehmer H 1988 Thymic major histocompatibility complex antigens and the alpha-beta T cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229-233
67. Germain RN 1994 MHC dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation Cell 76:287-299
68. Jin Y, Shin WK, Berkower I 1988 Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and non endosomal processing pathways are accessible to both endogenou and exogenous antigen. J Exp Med 168:293-306
69. Austyn JM, Smith KG, Morris PJ 1987 T cell activation by anti-CD antibodies: function of Fc receptors on B cell blasts, but not restin B cells, and CD18 on the responding T cells. Eur J Immunol 1: 1329-1335
70. Bohmig GA, Kovarik J, Holter W, Pohanka E, Zlabinger GJ 199 Specific downregulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol 152:3720-3728
71. Teunissen MB, Rongen HA, Bos JD 1994 Function of adhesic molecules lymphocyte function-associated antigen-3 and intercelular adhesion molecule-1 on human epidermal Langerhans cells antigen-specific T cell activation. J Immunol 152:3400-3409
72. Mueller DL, Jenkins MK, Schwartz RH 1989 Clonal expansion functional clonal inactivation: a co-stimulatory signalling pathw determines the outcome of T-cell antigen receptor occupan Annu Rev Immunol 7:445-480
73. Allison JP 1994 CD28-B7 interactions in T cell activation. Curr Opin Immunol 6:414-419
74. Norton SD, Zuckerman L, Urdahl KB, Shefner R, Miller J, Jenkins MK 1992 The CD28 ligand, B7, enhances II-2 production by providing a co-stimulatory signal to T-cells. J Immunol 149:1556-1561
75. June CH, Bluestone JA, Nadler LM, Thompson CB 1994 The B7 and CD28 receptor families. Immunol Today 15:321-331
76. Austyn JM 1987 Lymphoid dendritic cells. Immunology 62:161-170
77. Steinman RM 1991 The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296
78. van Voorhis WC, Valinsky J, Hoffman E, Luban J, Hair LS, Steinman RM 1983 Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J Exp Med 158:174-191
79. Caux C, Liu YS, Banchereau J 1995 Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 16:2-4
80. Prickett TCR, McKenzie JL, Hart DNJ 1992 Adhesion molecules of human tonsil dendritic cells. Transplantation 53:483-490
81. Hart DNJ, Prickett TCR 1993 Intercellular adhesion molecule-2 (ICAM-2) expression on human dendritic cells. Cell Immunol 148: 447-454
82. Inaba K, Steinman RM 1987 Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leucocyte reaction after the antigen dependent clustering of dendritic cells and T lymphocytes. J Exp Med 165:1403-1417
83. Hart DN, Starling GC, Calder VL, Fernando NS 1993 B7/BB1 is a leucocyte differentiation antigen on human dendritic cells induced by activation. Immunology 79:616-620
84. Kamperdijk EWA, van Vught E, Richters CD Beelen RHJ 1994 Morphology of dendritic cells. In: Bruijnzeel-Koomen CAFM, Hoefsmit ECM (eds) Immunopharmacology of Macrophages and Other Antigen-Presenting Cells. Academic Press Harcourt Brace and Company, New York, pp 45-61
85. Witmer MD, Steinman RM 1984 The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light microscopic immunocytochemical studies of mouse spleen, lymh node, and Peyer's patch. Am J Anat 170:465-481
86. Vakkila J, Sihvola M, Hurme M 1990 Human peripheral blood-derived dendritic cells do not produce interleukin 1-alpha, interleukin 1-beta or interleukin 6. Scand J Immunol 31:345-352
87. Hart DNJ, Calder VL 1993 Human dendritic cells: function and Cytokine production. In: Bruijnzeel-Koomen CAFM, Hoefsmit ECM (eds) Immunopharmacology of Macrophages and Other Antigen-Presenting Cells. Academic press Harcourt Brace and Company, New York, pp 63-91
88. Flechner ER, Freudenthal PS, Kaplan G, Steinman RM 1988 Antigen specific T lymphocytes efficiently cluster with dendritic cells in human primary mixed leucocyte reaction. Cell Immunol 111: 183-195
89. Austyn JM, Weinstein DE, Steinman RM 1988 Clustering with dendritic cells precedes and is essential for T-cell proliferation in a mitogenesis model. Immunology 63:691-696
90. Linsley PS, Clark EA, Ledbetter JA 1990 T-cell antigen CD28 mediates adhesion with B-cells by interacting with activation antigen B7/BB1. Proc Natl Acad Sci USA 87:5031-5035
91. Scott P 1993 II-12: initiation cytokine for cell-mediated immunity. Science 260:496-497
92. Moore KV, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR 1993 Interleukin 10. Annu Rev Immunol 11:165-190
93. d'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G 1993 Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/II-12 synthesis in accessory cells. J Exp Med 178:1041-1048
94. Nossal GJV 1987 Current concepts: immunology. The basic components of the immune system. N Engl J Med 316:1320-1325
95. Cooper MD 1987 Current concepts. B lymphocytes: normal development and function. N Engl J Med 317:1452-1456
96. Marrack P, Kappler J 1987 The T cell receptor. Science 238: 1073-1079
97. Royer HD, Reinherz EL 1987 T lymphocytes: ontogeny, function, and relevance to clinical disorders. N Engl J Med 317:1136-1142
98. Meuer SC, Acuto O, Hercend T, Schlossman SF, Reinherz EL 1984 The human T-cell receptor. Annu Rev Immunol 2:23-50
99. Moss PA, Rosenberg WM, Bell JI 1992 The human T cell receptor in health and disease. Annu Rev Immunol 10:71-96
100. Brenner MB, McLean J, Dialynas DP, Strominger JL, Smith JA, Owen FL, Seidman JG, Ip S, Rosen F, Krangel MS 1986 Identification of putative second T-cell receptor. Nature 322:145-149
101. Brenner MB, McLean J, Scheft H, Riberdy J, Ang SL Seidman JG, Devlin P, Krangel MS 1987 Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes. Nature 325:689-694
102. Allison JP, Lanier LL 1987 Structure, function, and serology of the T-cell antigen receptor complex. Annu Rev Immunol 3:503-540
103. Leder P 1982 The genetics of antibody diversity. Sci Am 246: 102-115
104. Tonegawa S 1983 Somatic generation of antibody diversity. Nature 302:575-581
105. Oettgen HC, Kappler J, Tax WJ, Terhorst C 1984 Characterization of the two heavy chains of the T3 complex on the surface of human T lymphocytes. J Biol Chem 259:12039-12048
106. Borst J, Coligan JE, Oettgen H, Pessano S, Malin R, Terhorst C 1984 The delta and epsilon chains of the human T3/T-cell receptor complex are distinct polypeptides. Nature 312:455-458
107. Collins TL, Kassner PD, Bierer BE, Burakoff SJ 1994 Adhesion receptors in lymphocyte activation. Curr Opin Immunol 6:385-393
108. Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ 1989 The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol 7:579-599
109. Mosmann TR, Coffman RL 1989 Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
110. Romagnani S 1989 Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98:279-285
111. Powrie F, Menon S, Coffman RL 1993 Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:2223-2229. (published erratum appears in Eur J Immunol 1994 24:785)
112. Quill H, Gaur A, Phipps RP 1989 Prostaglandin E2-dependent induction of granulocyte-macrophage colony-stimulating factor secretion by cloned murine helper T cells. J Immunol 142:813-818
113. Betz M, Fox BS 1991 Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146:108-113
114. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT 1990 Cholera toxin discriminates between T helper 1 and 2 cells in T receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 172:95-103
115. Johnson HM, Torres BA 1984 Leukotrienes: positive signals for regulation of gamma-interferon production. J Immunol 132:413-416
116. Myers CD 1991 Role of B cell antigen processing and presentation in the humoral immune response. FASEB J 5:2547-2553. (published erratum appears in FASEB J 1991 5:285)
117. Parker DC 1993 T cell-dependent B cell activation. Annu Rev Immunol 11:331-360
118. Burton DR 1987 Structure and function of antibodies. In: Calabi F, Neuberger MS (eds) Molecular Genetics of Immunoglobulin. Elsevier Science Publishers. Amsterdam, pp 1-50
119. Shimizu A, Honjo T 1984 Immunoglobulin class switching. Cell 36:801-803
120. Krawinkel U, Radbuch A 1987 Immunoglobulin heavy chain class switctching. In: Calabi F, Neuberger MS (eds) Molecular Genetics of Immunoglobulin. Elsevier Science Publishers, Amsterdam, pp 135-151
121. Griffin Jr FM, Griffin JA, Leider JE, Silverstein SC 1975 Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane. J Exp Med 142:1263-1282
122. Campbell PA, Canono BP, Cook JL 1988 Mouse macrophages stimulated by recombinant gamma-interferon to kill tumor cells are not bactericidal for facultative intracellular bacterium Listeria monocytogenes. Infect Immun 56:1371-1375
123. Green JG, Turpin JA, Nacy CA 1995 Cytotoxic effector activities of macrophages. In: RR Rich, TA Fleischer, BD Schwartz, WT Shearer, W Strober (eds) Clinical Immunology, Principles and Practice. Mosby 1996, St. Louis, MO, vol 1:290-298
124. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N 1987 Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 329:630-632
125. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF 1989 Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci USA 86:2229-2233
126. Greenberger JS 1991 The hematopoietic microenvironment. Crit Rev Oncol Hematol 11:65-84
127. van Ewijk W 1991 T-cell differentiation is influenced by thymic microenvironment. Annu Rev Immunol 9:591-615
128. Leenen PJM, Campbell PA 1993 Heterogeneity of mononuclear phagocytes. An interpretive review. In: Horton MA (ed) Blood Cell Biochemistry: Macrophages and Related cells. Plenum Press, New York, vol 5:29-85
129. van Furth R 1992 Development and distribution of mononuclear phagocytes. In: Gallin JI, Goldstein IM, Snijderman R (eds) Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York
130. Trinchieri G 1989 Biology of natural killer cells. Adv Immunol 47:187-316
131. Lanier LL, Cwirla S, Federspiel N, Phillips J 1986 Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J Exp Med 163:209-214
132. Perussia B, London L, Trichieri G 1985 Phenotypic characteristics of human natural killer cells. Biomed Pharmacother 39:13-18
133. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH 1986 The relationship of CD16 (Le-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480-4486
134. Nagler A, Lanier LL, Phillips JH 1990 Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med 171:1527-1533
135. Herberman RB, Nunn ME, Holden HT, Lavrin DH 1975 Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 16:230-239
136. Kiessling R, Klein E, Pross H, Wigzell H 1975 "Natural" killer cells in the mouse II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5:117-121
137. Podack ER 1992 Perforin: structure, function, and regulation. Curr Top Microbiol Immunol 178:175-184
138. Seaman WE 1995 Natural killer cells. In: Rich RR, Fleischer TA, Schwartz BD, Shearer WT, Strober W (eds) Clinical Immunology, Principles and Practice. Mosby 1996, St. Louis, MO, vol 1:282-289
139. Yuan D, Koh CY, Wilder JA 1994 Interactions between B lymphocytes and NK cells. FASEB J 8:1012-1018
140. Suda T, Takahashi T, Golstein P, Nagata S 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178
141. Biddison WE 1995 Cytotoxic T cell function. In: Rich RR, Fleischer TA, Schwartz BD, Shearer WT, Strober W (eds) Clinical Immunology, Principles and Practice. Mosby 1996, St. Louis, MO, vol 1:276-281
142. Kroemer G, Martinez C 1992 Mechanisms of self tolerance. Immunol Today 13:401-404
143. Kappler JW, Roehm N, Marrack P 1987 T cell tolerance by clonal elimination in the thymus. Cell 49:273-280
144. Murphy KM, Heimberger AB, Loh DY 1990 Induction of antigen of intrathymic apoptosis of CD4+CD8+TCR+ thymocytes in vivo. Science 250:1720-1723
145. Anonymous 1986 Autoimmunity: experimental and clinical aspects. Ann NY Acad Sci 475:1-427
146. Goodnow CC, Adelstein S, Basten A 1990 The need for central and peripheral tolerance in the B cell repertoire. Science 248:1373-1379
147. Kimura H, Davies TF 1991 Thyroid-specific T cells in the normal Wistar rat. II. T cell clones interact with cloned Wistar rat thyroid cells and provide direct evidence for autoantigen presentation by thyroid epithelial cells. Clin Immunol Immunopathol 58:195-206
148. Schwartz RH 1990 A culture model for T lymphocyte clonal anergy. Science 248:1349-1356
149. Morahan G, Allison J, Miller JF 1989 Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 339:622-624
150. Mohler KM, Streilein JW 1989 Differential expression of helper vs. effector activity in mice rendered neonatally tolerant of class II MHC antigens. Transplantation 47:633-640
151. Voorbij HA, Kabel PJ, de Haan M, Jeucken PH, van der Gaag RD, de Baets MH, Drexhage HA 1990 Dendritic cells and class II MHC expression on thyrocytes during autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol 55:9-22
152. Hanafusa T, Pujol-Borell R, Chiovato L, Doniach D, Russell RC, Doniach D, Bottazzo GF 1983 Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2:1111-1115
153. Iwatani Y, Amino N, Miyai K 1989 Peripheral self tolerance and autoimmunity: the protective role of expression of class II major histocompatibility antigens on non-lymphoid cells. Biomed Pharmacother 43:593-605
154. Miller A, Hafler DA, Weiner HL 1991 Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. FASEB J 5:2560-2566
155. Batchelor JR, Lombardi G, Lechler RI 1989 Speculations on the specificity of suppression. Immunol Today 10:37-40
156. Day MJ, Tse AG, Puklavec M, Simmonds SJ, Mason DW 1992 Targeting autoantigen to B cells prevents the induction of a cell mediated autoimmune disease in rats. J Exp Med 175:655-659
157. Milgrom F, Witebsky E 1962 Autoantibodies and autoimmune disease. JAMA 181:706-717
158. Bottazzo GF 1993 Banting Lecture. On the honey disease. A dialogue with socrates. Diabetes 42:778-800
159. Wick G, Brezinschek HP, Hala K, Dietrich H, Wolf H, Kroemer G 1989 The obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis. Adv Immunol 47:433-500
160. Voorbij HA, van der Gaag RD, Jeucken PH, Bloot AM, Drexhage HA 1989 The goitre of the BB/O rat: an animal model for studying the role of immunoglobulins stimulating growth of thyroid cells. Clin Exp Immunol 76:290-295
161. Sakaguchi S, Sakaguchi N 1989 Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol 142:471-480
162. Kabel PJ, Voorbij HA, de Haan M, van der Gaag RD, Drexhage HA 1988 Intrathyroidal dendritic cells. J Clin Endocrinol Metab 65:199-207
163. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF 1995 Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 147:311-320
164. Yoon JW 1990 The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol 164:95-123
165. Charlton B, Bacelj A, Slattery RM, Mandel TE 1989 Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38:441-447
166. Mooy P 1993 The Thyroid, Iodine and Autoimmunity. Thesis, University of Rotterdam, Rotterdam, The Netherlands
167. Colle E, Guttmann RD, Seemayer T 1981 Spontaneous diabetes mellitus syndrome in the rat. I. Association with major histocompatibility complex. J Exp Med 154:1237-1242
168. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, Rodrigues N, Lathrop M, Pressey A, DeLarato NH, Peterson LB, Wicker LS 1991 Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature 351:542-547
169. Serreze DV, Gaedeke JW, Leiter EH 1993 Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/It mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 90:9625-9629
170. Greiner DL, Handler ES, Nakono K, Mordes JP, Rossini AA 1986 Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 136:148-151
171. Volpe R 1988 The immunoregulatory disturbances in autoimmune thyroid disease. Autoimmunity 2:55-72
172. Wick G, Hu Y, Schwarz S, Kroemer G 1993 Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr Rev 14:539-563
173. Wick G, Trieb K, Aguzzi A, Recheis H, Anderl H, Grubeck-Loebenstein B 1993 Possible role of human foamy virus in Graves' disease. Intervirology 35:101-107
174. Theofilopoulos AN 1995 The basis of autoimmunity. II. Genetic predisposition. Immunol Today 16:150-159
175. Epplen JT, Buitkamp J, Bocker T, Epplen C 1995 Indirect gene diagnoses for complex (multifactorial) diseases, a review. Gene 159:49-55
176. van Dongen JJM, Groeneveld K, Adriaansen HJ, Hooijkaas H 1994 Immunofenotypering in de diagnostiek: indicatiestellingen, uitvoering en interpretatie. Afd. Immunologie, Erasmus Universiteit, Rotterdam, pp 27-40
177. Turkington RW, Lebovitz HE 1967 Extra-adrenal endocrine deficiencies in Addison's disease. Am J Med 43:499-507
178. Wulffraat NM, Drexhage HA, Bottazzo GF 1992 Autoimmune aspects of Addison's disease. In: James VHT (ed) The Adrenal Gland, ed 2. Raven Press, New York, pp 263-288
179. Munro Neville A, O'Hara MJ 1982 The Human Adrenal Cortex. Springer-Verlag, Berlin
180. Muir A, Schatz DA, MacLaren NK 1995 Autoimmune polyglandular syndrome. In: de Groot LS (ed) Endocrinology, ed. 3. WB Saunders, Philadelphia, pp 3013-3024
181. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, Caretto A 1993 Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 39:35-43
182. Golonka JE, Goodman AD 1968 Coexistence of primary ovarian insufficiency, primary adrenocortical insufficiency and idiopathic hypoparathyroidism. J Clin Endocrinol Metab 28:79-82
183. Labarbera AR, Miller MM, Ober C, Rebar RW 1988 Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 16:115-122
184. Blizzard RM, Chee D, Davies W 1967 The incidence of adrenal and other antibodies in sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol 2:19-30
185. Irvine WJ, Chan MMW, Scarth L, Kolb FO, Hartog M, Bayliss RIS, Drury MI 1968 Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 2:883-887
186. Sotsiou F, Bottazzo GF, Doniach D 1980 Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine diseases and infertility. Clin Exp Immunol 39:97-111
187. Elder M, MacLaren N, Riley W 1981 Gonadal autoantibodies in patients with hypogonadism and/or Addison's disease. J Clin Endocrinol Metab 52:1137-1142
188. Ahonen P, Miettinen A, Perheentupa J 1987 Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 64:494-500
189. McNatty KP, Short RV, Barnes EW, Irvine WJ 1975 The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cells in culture. Clin Exp Immunol 22:378-384
190. Furmaniak J, Kominami S, Asawa T, Wedlock N, Colls J, Smith BR 1994 Autoimmune Addison's disease - evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J Clin Endocrinol Metab 79:1517-1521
191. Winqvist O, Karlsson FA, Kämpe O 1992 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339:1559-1562
192. Baumann-Antczak A, Wedlock N, Bednarek J, Kiso Y, Krishnan H, Fowler S, Smith BR, Furmaniak J 1992 Autoimmune Addison's disease and 21-hydroxylase. Lancet 340:429-430
193. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K 1992 Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17-α-hydroxylase. Lancet 339:770-773
194. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O 1993 Two different cytochrome p450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 92:2377-2385
195. Uibo R, Perheentupa J, Ovod V, Krohn KJ 1994 Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I. J Autoimmun 7:399-411
196. Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ 1994 Autoantibodies to cytochrome p450 enzymes p450 scc, p450c17, and p450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 78:323-328
197. Velloso LA, Winqvist O, Gustafsson J, Kämpe O, Karlsson FA 1994 Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Diabetologia 37:61-69
198. Song YH, Connor EL, Muir A, She SX, Zorovich B, Derovanesian D, Maclaren N 1994 Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J Clin Endocrinol Metab 78:1108-1112
199. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O 1993 Two different cytochrome P450 enzymes type I are the adrenal antigens in autoimmune antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 92:2377-2385
200. Bannatyne P, Russell P, Shearman RP 1990 Autoimmune oöphoritis: a clinicopathologic assessment of 12 cases. Int J Gynaecol Pathol 9:191-207
201. Sedmak DD, Hart WR, Tubbs RR 1987 Autoimmune oöphoritis: a
202. Gloor E, Hurlimann J 1984 Autoimmune oöphoritis. Am J Clin Pathol 81:105-109
203. Edmonds M, Lamki L, Killinger DW, Volpe R 1973 Autoimmune thyroiditis, adrenalitis and oöphoritis. Am J Med 54:782-787
204. Bottazzo GF, Mirakian R, Drexhage HA 1996 Adrenalitis, oöphoritis and autoimmune polyglandular disease. In: Rich RR et al. (eds) Clinical Immunology, Principles and Practice. Mosby, St. Louis, MO, chapter 100, pp 1523-1536
205. Ahonen P, Koskimies S, Lokki ML, Tiilikainen A, Perheentupa J 1988 The expression of autoimmune polyglandular disease type 1 appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab 66:1152-1157
206. Aaltonen J, Björses P, Sandkuijl L, Perheentupa J, Peltonen L 1994 An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type 1 assigned to chromosome 21. Nat Genet 8:83-87
207. Yamakawa K, Mitchell S, Hubert R, Chen XN, Colbern S, Huo YK, Gadomski C, Kim UJ, Korenberg JR 1995 Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum Mol Genet 4:709-716
208. Dewhurst CJ, De Koos EB, Ferreira HP 1975 The resistant ovary syndrome. Br J Obstet Gynecol 82:341-345
209. Zourlas PA, Comninos AC 1971 Primary amenorrhea with normally developed secondary sex characteristics. Obstet Gynecol 38: 298-303
210. Koninckx PR, Brosens IA 1977 The "gonadotropin-resistant ovary" syndrome as a cause of secondary amenorrhea and infertility. Fertil Steril 28:926-931
211. Kim MH 1974 "Gonadotropin-resistant ovaries" syndrome in association with secondary amenorrhea. Am J Obstet Gynecol 120: 257-263
212. Kuki S, Morgan RL, Tucci JR 1981 Myasthenia gravis and premature ovarian failure. Arch Intern Med 141:1230-1232
213. Escobar ME, Cigorraga SB, Chiauzzi VA, Charreau EH, Rivarola MA 1982 Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms. Acta Endocrinol (Copenh) 99:431-436
214. Shangold MM, Turksoy RN, Bashford RA, Hammond CB 1977 Pregnancy following the "insensitive ovary syndrome". Fertil Steril 28:1179-1181
215. Maxson WS, Wentz AC 1983 The gonadotropin resistant ovary syndrome. Semin Reprod Endocrinol 1:147-160
216. Tsirigotis M, Craft IL 1994 Benign thymoma and resitant ovary syndrome. Br J Obstet Gynaecol 101:350-352
217. Dahl KD, Biesak TA, Hsueh AJ 1988 Naturally occurring antihormones: secretion of FSH antagonists by women treated with GnRH analog. Science 239:72-74
218. Sluss PM, Schneyer AL 1992 Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J Clin Endocrinol Metab 74:1242-1246
219. Muechler EK, Huang KE, Schenk E 1991 Autoimmunity in premature ovarian failure. Int J Fertil 36:99-103
220. Moncayo-Naveda HE, Moncayo R, Benz R, Wolf A, Lauritzen C 1989 Organ-specific antibodies against ovary in patients with system lupus erythematosus. Am J Obstet Gynecol 160:1227-1229
221. de Moraes-Ruehsen M, Blizzard RM, Garcia-Bunuel R, Jones GS 1972 Autoimmunity and ovarian failure. Am J Obstet Gynecol 112:693-703
222. Friedman S, McCormick JN, Fudenberg HH, Goldfien A 1972 Ovarian antibodies in disorders of ovarian function. Clin Immunol Immunopathol 1:94-103
223. Rabinowe SL, Ravnikar VA, Dib SA, George KL, Dluhy RG 1989 Premature menopause: monoclonal antibody defined T lymphocyte abnormalities and antiovarian antibodies. Fertil Steril 51:450-454
224. Pekonen F, Siegberg R, Makinen T, Miettinen A, Yli-Korkala O 1986 Immunological disturbances in patients with premature ovarian failure. Clin Endocrinol (Oxf) 25:1-6
225. Mathur S, Peress MR, Williamson HO, Youmans CD, Maney SA, Garvin AJ, Rust PF, Fudenberg HH 1982 Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 50: 259-266
226. Coulam CB, Ryan RJ 1979 Premature menopause. I. Etiology. Am J Obstet Gynecol 133:639-643
227. Coulam CB, Ryan RJ 1985 Prevalence of circulating antibodies directed towards ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 9:23-24
228. Damewood MD, Zacur HA, Hoffman GJ, Rock JA 1986 Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 68:850-854
229. Luborsky JL, Visintin I, Boyers SP, Asari T, Caldwell B, DeCherney A 1990 Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 70:69-75
230. DeGroot LJ, Quintans J 1989 The causes of autoimmune thyroid disease. Endocr Rev 10:537-562
231. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R 1986 Organ-specific autoimmunity: a 1986 overview. Immunol Rev 94: 137-169
232. Austin GE, Coulam CB, Ryan RJ 1979 A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc 54:394-400
233. Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH 1982 Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 54:1221-1228
234. Tang VW, Faiman C 1983 Premature ovarian failure: a search for circulating factors against gonadotropin receptors. Am J Obstet Gynecol 146:816-821
235. van Weissenbruch MM, Hoek A, van Vliet-Bleeker I, Schoemaker J, Drexhage H 1991 Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J Clin Endocrinol Metab 73:360-367
236. Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP 1994 Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 96:122-128
237. Anasti JN, Flack MR, Froelich J, Nelson LM 1995 The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 80:824-828
238. Moncayo H, Moncayo R, Bentz R, Wolf A, Lauritzen C 1989 Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/ human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest 84:1857-1865
239. Moncayo R, Moncayo H, Dapunt O 1990 Immunological risks of IVF (letter). Lancet 335:180
240. Jia XC, Oikawa M, Bo M, Tanaka T, Ny T, Boime I, Hsueh AJ 1991 Expression of human luteinizing hormone receptor: interaction with LH and chorion gonadotropin from human but not equine, rat, and ovine species. Mol Endocrinol 5:759-768
241. Tilly JL, Aihara T, Nishimori K, Jia XC, Billig H, Kowalski KI, Perlas EA, Hsueh AJ 1992 Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology 131:799-806
242. Kamada M, Daitoh T, Mori K, Maeda N, Hirano K, Irahara M, Aono T, Mori T 1992 Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 28:104-109
243. Jansen A 1995 Dendritic Cells, Macrophages in Insulin Dependent Diabetes Mellitus. Thesis, Rotterdam
244. Miyake T, Sato Y, Takeuchi S 1987 Implications of circulating autoantibodies and peripheral blood lymphocytes for the genesis of premature ovarian failure. J Reprod Immunol 12:163-171
245. Ho PC, Tang GW, Fu KH, Fan MC, Lawton JW 1988 Immunologic studies in patients with premature ovarian failure. Obstet Gynecol 71:622-626
246. Mignot MH, Drexhage HA, Kleingeld M, Van de Plassche-Boers EM, Rao BR, Schoemaker J 1989 Premature ovarian failure. II. Considerations of cellular immunity defects. Eur J Obstet Gynecol Reprod Biol 30:67-72
247. Nelson LM, Kimzey LM, Merriam GR, Fleisher TA 1992 Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil Steril 55: 1082-1087
248. Hoek A, van Kasteren Y, de Haan-Meulman M, Hooijkaas H, Schoemaker J, Drexhage HA 1995 Analysis of peripheral blood lymphocyte subsets, NK cells, and delayed type hypersensitivity skin test in patients with premature ovarian failure. Am J Reprod Immunol 33:495-502
249. Jackson RA, Haynes BF, Burch WM, Shimizu K, Bowring MA, Eisenbarth GS 1984 Ia + T cells in new onset Graves' disease. J Clin Endocrinol Metab 59:187-190
250. Jackson RA, Morris MA, Haynes BF, Eisenbarth GS 1982 Increased circulating Ia antigen-bearing T cells in type I diabetes mellitus. N Engl J Med 306:785-788
251. Rabinowe SL, Jackson RA, Dluhy RG, Williams GH 1984 Ia + T lymphocytes in recently diagnosed idiopathic Addison's disease. Am J Med 77:597-601
252. Ho PC, Tang GWK, Lawton JW 1993 Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement. Hum Reprod 8:714-716
253. Marazuela M, Vargas JA, Alvarez-Mon M, Albarran F, Lucas T, Durantez A 1995 Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease. Eur J Endocrinol 132: 175-180
254. Jansen A, van Hagen M, Drexhage HA 1995 Defective maturation and function of antigen-presenting cells in type I diabetes. Lancet 345:491-493
255. Tas M, de Haan-Meulman M, Kabel PJ, Drexhage HA 1991 Defects in monocyte polariztion and dendritic cell clustering in patients with Graves' disease. A putative role for a non-specific immunoregulatory factor related to retroviral P15E. Clin Endocrinol (Oxf) 34:441-448
256. Hoek A, van Kasteren Y, de Haan-Meulman M, Schoemaker J, Drexhage HA 1993 Dysfunction of monocytes and dendritic cells in patients with premature ovarian failure. Am J Reprod Immunol 30:207-217
257. Mathur S, Melchers III JT, Ades EW, Williamson HO, Fudenberg HH 1980 Anti-ovarian and anti-lymphocyte antibodies in patients with chronic vaginal candidiasis. J Reprod Immunol 2:247-262
258. Walfish PG, Gottesman IS, Shewchuk AB, Bain J, Hawe BS, Farid NR 1983 Association of premature ovarian failure with HLA antigens. Tissue Antigens 21:168-169
259. Anasti JN, Adams S, Kimzey LM, Defensor RA, Zachary AA, Nelson LM 1994 Karyotypically normal spontaneous premature ovarian failure: evaluation of association with class II major histocompatibility complex. J Clin Endocrinol Metab 78:722-723
260. Jaroudi KA, Arora M, Sheth KV, Sieck UV, Willemsen WN 1994 Human leucocyte antigen typing and associated abnormalities in premature ovarian failure. Hum Reprod 9:2006-2009
261. Sakaguchi S, Sakaguchi N 1989 Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol 142:471-480
262. Taguchi O, Takahashi T, Masao S, Namikawa R, Matshyama M, Nishizuka Y 1986 Development of multiple organ-localized autoimmune diseases in nude mice after reconstitution of T cell function by rat fetal thymus graft. J Exp Med 164:60-71
263. Sakaguchi S, Sakaguchi N 1990 Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J Exp Med 172:537-545
264. Smith H, Lou YH, Lacy P, Tung KS 1992 Tolerance mechanism in experimental ovarian and gastric autoimmune diseases. J Immunol 149:2212-2218
265. Jankovic BD, Markovic BM, Petrovic S, Isakovic K 1973 Experimental autoimmuno-oophoritis in the rat. Eur J Immunol 3:375-377
266. Damjanovic M, Janovic BD 1989 Experimental autoimmune oophoritis. I. Inhibition of fertility in rats isoimmunized with homogenates of the ovary. Am J Reprod Immunol 20:1-8
267. Ivanova M, Bourneva V, Gitsov L, Angelova Z 1984 Experimental immune oophoritis as a model for studying the thymus ovary interaction. I. Morphological studies. Am J Reprod Immunol 6:99-106
268. Damjanovic M 1991 Experimental autoimmune oophoritis. II. Both Iymphoid cells and antibodies are successful in adoptive transfer. Autoimmunity 9:217-223
269. Wood DM, Liu C, Dunbar BS 1981 The effect of alloimmunization and heteroimmunization with zonae pellucidae on fertility in rabbits. Biol Reprod 25:439-450
270. Skinner SM, Mills T, Kirchick HJ, Dunbar BS 1984 Immunization with zona pellucida proteins results in abnormal ovarian follicular differentiation and inhibition of gonadotropin-induced steroid secretion. Endocrinology 115:2418-2432
271. Anonymous 1986 Case records of the Massachusett's General hospital. Weekly clinicopathological exercises. Case 46-1986: a 26-year-old woman with secondary amenorrhea. N Engl J Med 315: 1336-1343
272. Anonymous 1987 Case records of the Massachusett's General Hospital. Case 46-1987: a 31-year-old woman with secondary amenorrhea. N Engl J Med 317:1270-1278
273. Rhim SH, Millar SE, Robey F, Luo AM, Lou YH, Yule T, Allen P, Dean J, Tung KS 1992 Autoimmune diseases of the ovary induced by ZP3 peptide from the mouse zona pellucida. J Clin Invest 89:28-35
274. Dean J 1992 Biology of mammalian fertilization: role of the zona pellucida. J Clin Invest 89:1055-1059
275. Lou Y, Tung KS 1993 T cell peptide of a self-protein elicits autoantibody to the protein antigen. Implications for specificity and pathogenetic role of antibody in autoimmunity. J Immunol 151: 5790-5799
276. Luo AM, Garza KM, Hunt D, Tung KS 1993 Antigen mimicry in autoimmune disease: x sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest 92:2117-2123
277. Chamberlin ME, Dean J 1990 Human homolog of the mouse sperm receptor. Proc Natl Acad Sci USA 87:6014-6018
278. Taguchi O, Nishizuka Y, Sakakura T, Kojima A 1980 Autoimmune oophoritis in thymectomized mice: detection of circulating antibodies against oocytes. Clin Exp Immunol 40:540-553
279. Miyake T, Taguchi O, Ikeda H, Sato Y, Takeuchi S, Nishizuka Y 1988 Acute oocyte loss in experimental autoimmune oophoritis as a possible model of premature ovarian failure. Am J Obstet Gynecol 158:186-192
280. Tung KS, Smith S, Teuscher C, Cook C, Anderson RE 1987 Murine autoimmune oophoritis, epididymo-orchitis, and gastritis induced by day 3 thymectomy. Am J Pathol 126:293-302
281. Taguchi O, Nishizuka Y 1980 Autoimmune oophoritis in the thymectomized mice: T cell requirement in the adoptive cell transfer. Clin Exp Immunol 42:324-331
282. Sakaguchi S, Takahashi T, Nishizuka Y 1982 Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 156:1565-1576
283. Smith H, Sakamoto Y, Kasai K, Tung KSK 1991 Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 147:2928-2933
284. Wardell BB, Michael SD, Tung KS, Todd JA, Blankenhorn EP, McEnter K, Sudweeks JD, Hansen WK, Meeker ND, Griffith JS, Livingstone KD, Teuscher C 1995 Aod 1, the immunoregulatory locus controlling abrogation of tolerance in neonatal thymectomy-induced autoimmune ovarian dysgenesis, maps to mouse chromosome 16. Proc Natl Acad Sci USA 92:4758-4762
285. Meeker ND, Hickey WF, Korngold R, Hansen WK, Sudweeks JD, Wardell BB, Griffith JS, Teuscher C 1995 Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc Natl Acad Sci USA 92:5684-5688
286. Smith H, Chen IM, Kubo R, Tung KS 1989 Neonatal thymectomy results in a repertoire enriched in T cells deleted in adult thymus. Science 245:749-752
287. Miller ME, Chatten J 1967 Ovarian changes in ataxia telangiectasia. Acta Paediatr Scand 56:559-561
288. Cowchock FS, McCabe JL, Montgomery BB 1988 Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 158:118-119
289. Blumenfeld Z, Halachmi S, Peretz BA, Shmuel Z, Golan D, Makler A, Brandes JM 1993 Premature ovarian failure. The prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 59:750-755
290. Corenblum B, Rowe T, Taylor PJ 1993 High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 59:988-991
291. Lundberg PO, Persson BH 1969 Disappearance of amenorrhea after thymectomy. Case report. Acta Soc Med Ups 74:206-208
292. Bateman BG, Nunley Jr WC, Kitchin III JD 1983 Reversal of apparent premature ovarian failure in a patient with myastenia gravis. Fertil Steril 39:108-110
293. Irvine WJ 1980 Autoimmunity in endocrine disease. Recent Prog Horm Res 36:509-556
294. Coulam CB, Kempers RD, Randall RV 1981 Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 36: 238-240
295. Rabinowe SL, Berger MJ, Welch WR, Dluhy RG 1986 Lymphocyte dysfunction in autoimmune oophoritis. Resumption of menses with corticosteroids. Am J Med 81:347-350
296. Wolfe CD, Stirling RW 1988 Premature menopause associated with autoimmune oophoritis. Case report. Br J Obstet Gynecol 95:630-632
297. Biscotti CV, Hart WR, Lucas JG 1989 Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 74:492-495
298. Lonsdale RN, Roberts PF, Trowell JE 1991 Autoimmune oophoritis associated with polycystic ovaries. Histopathology 19:77-81
299. Russell P, Bannatyne P, Shearman RP, Fraser IS, Corbett P 1982 Premature hypergonadotropic ovarian failure: clinicopathological study of 19 cases. Int J Gynecol Pathol 1:185-201
300. Friedman CI Gurgen-Varol F, Lucas J, Neff J 1987 Persistent progesterone production associated with autoimmune oophoritis. A case report. J Reprod Med 32:293-296
301. Emperaire JC, Audebert A, Greenblatt RB 1970 Premature ovarian failure. Report of seven cases. Am J Obstet Gynecol 108:445-449
302. Zarate A, Karchmer S, Gomez E, Castelazo-Ayala L 1970 Premature menopause. A clinical, histologic, and cytogenetic study. Am J Obstet Gynecol 106:110-114
303. Sharf M, Israeli I, Graff G 1972 The value of ovarian biopsy in the diagnosis and treatment of amenorrhoea related sterility. Obstet Gynecol 39:89-94
304. Falk RJ 1977 Euestrogenic ovarian failure. Fertil Steril 28:502-503
305. Duignan NM, Shaw RW, Glass MR, Butt WR, Edwards RL 1978 Sex hormone levels and gonadotrophin release in premature ovarian failure. Br J Obstet Gynaecol 85:862-867
306. Board JA, Redwine AO, Moncure CW, Frable WJ, Taylor JR 1979 Identification of differing etiologies of clinically diagnosed premature menopause. Am J Obstet Gynecol 134:936-944
307. Menon V, Edwards RL, Butt WR, Bluck M, Lynch SS 1984 Review of 59 patients with hypergonadotrophic amenorrhoea. Br J Obstet Gynaecol 91:63-66
308. Aiman J, Smentek C 1985 Premature ovarian failure. Obstet Gynecol 66:9-14
309. Rebar RW, Connolly HV 1990 Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 53:804-810
310. Behrman SJ 1964 Discussion. Am J Obstet Gynecol 89:94-95
311. Vallotton MB, Forbes AP 1969 Premature menopause in autoimmune diseases. Lancet 1:156-157
312. Ayala A, Canales ES, Karchmer S, Alarcon D, Zarate A 1979 Premature ovarian failure and hypothyroidism associated with sicca syndrome. Obstet Gynecol 53[Suppl 3]:985-1015
313. Collen RJ, Lippe BM, Kaplan SA 1979 Primary ovarian failure, juvenile rheumatoid arthritis, and vitiligo. Am J Dis Child 133: 598-600
314. Williamson HO, Phansey SA, Mathur S, Mathur RS, Baker ER, Fundenberg HH 1980 Myasthenia gravis, premature menopause, and thyroid autoimmunity. Am J Obstet Gynecol 137:893-901
315. Coulam CB, Lufkin EG 1981 Absence of adrenal failure in the polyglandular failure syndrome with primary ovarian failure. Fertil Steril 35:365-366
316. Mignot MH, Schoemaker J, Kleingeld M, Rao BR, Drexhage HA 1989 Premature ovarian failure. I. The association with autoimmunity. Eur J Obstet Gynecol Reprod Biol 30:59-66
317. Wolffenbuttel BH, Weber RF, Prins ME, Verschoor L 1987 Premature ovarian failure and autoimmune hypothyroidism in the absence of Addison's disease. Neth J Med 30:128-134
318. Belvisi L, Bombelli F, Sironi L, Doldi N 1993 Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest 16:889-892